Norrett Kevin — SEC Form 4 filings

SEC reporting owner CIK 1819690. 4 Form 4 filings on record with FilingPulse; latest filed 2026-05-18.

Transaction summary — filings shown

Covers all 4 filings on record, filed 2025-02-07 to 2026-05-18. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
SOLENO THERAPEUTICS INC (SLNO)Chief Business Officer37
CODEXIS, INC. (CDXS)Chief Operating Officer12

Form 4 filings — Norrett Kevin

FiledFormIssuerReported transactionsSource
2026-05-184SOLENO THERAPEUTICS INC (SLNO)Disposition to issuer (D): 17,786 · Disposition to issuer (D): 64,286 (derivative) · Disposition to issuer (D): 4,000 (derivative)EDGAR
2026-01-234SOLENO THERAPEUTICS INC (SLNO)Grant/award (A): 3,500 @ $0 · Grant/award (A): 4,000 (derivative) @ $0EDGAR
2025-11-194SOLENO THERAPEUTICS INC (SLNO)Grant/award (A): 14,286 @ $0 · Option exercise (M): 64,286 (derivative) @ $0EDGAR
2025-02-074CODEXIS, INC. (CDXS)Grant/award (A): 26,875 @ $0 · Grant/award (A): 161,250 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1819690 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →